Spots Global Cancer Trial Database for uterine serous carcinoma
Every month we try and update this database with for uterine serous carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | NCT04814108 | Uterine Serous ... | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma | NCT04814108 | Uterine Serous ... | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
A Study of Adavosertib as Treatment for Uterine Serous Carcinoma | NCT04590248 | Uterine Serous ... | Adavosertib | 18 Years - 130 Years | AstraZeneca | |
A Study of ZN-c3 in Participants With Solid Tumors | NCT04158336 | Solid Tumor | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma | NCT04080284 | Endometrial Can... Papillary Serou... Uterine Serous ... Endometrial Car... Cancer of the E... | Niraparib | 18 Years - | Northwell Health | |
A Study of ZN-c3 in Participants With Solid Tumors | NCT04158336 | Solid Tumor | ZN-c3 | 18 Years - | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | |
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | NCT05902988 | Advanced Solid ... High Grade Sero... Squamous Non-sm... Triple Negative... Gastric Adenoca... Colorectal Aden... Esophageal Squa... Esophageal Aden... Gastroesophagea... Transitional Ce... Head and Neck S... Ovarian Carcino... Uterine Carcino... Uterine Serous ... Endometrium Can... Chromosomal Ins... | VLS-1488 | 18 Years - | Volastra Therapeutics, Inc. |